Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Motus GI Holdings's share price for the quarter that ended in Dec. 2023 was $1.275. Motus GI Holdings's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 1.55 Mil. Therefore, Motus GI Holdings's market cap for the quarter that ended in Dec. 2023 was $1.97 Mil.
Motus GI Holdings's quarterly market cap
increased
from Jun. 2023 ($3.55 Mil) to Sep. 2023 ($3.58 Mil) but then
declined
from Sep. 2023 ($3.58 Mil) to Dec. 2023 ($1.97 Mil).
Motus GI Holdings's annual market cap
declined
from Dec. 2021 ($22.57 Mil) to Dec. 2022 ($3.91 Mil) and
declined
from Dec. 2022 ($3.91 Mil) to Dec. 2023 ($1.97 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Motus GI Holdings's Enterprise Value for Today is $-2.07 Mil.
Motus GI Holdings Market Cap Historical Data
The historical data trend for Motus GI Holdings's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Motus GI Holdings's Market Cap
For the Medical Devices subindustry, Motus GI Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Motus GI Holdings's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Motus GI Holdings's Market Cap distribution charts can be found below:
* The bar in red indicates where Motus GI Holdings's Market Cap falls into.
Motus GI Holdings Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Motus GI Holdings's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Motus GI Holdings (OTCPK:MOTS) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Motus GI Holdings Market Cap Related Terms
Thank you for viewing the detailed overview of Motus GI Holdings's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Motus GI Holdings (Motus GI Holdings) Business Description
Motus GI Holdings Inc is a medical technology company dedicated to improving endoscopy outcomes, lowering costs and enhancing patient experiences. The company has developed the Pure-Vu System, a medical device that has been cleared by the U.S. Food and Drug Administration (the "FDA") to help facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and to help facilitate upper gastrointestinal ("GI") endoscopy procedures. The Pure-Vu System is also CE marked in the European Economic Area (EEA) for use in colonoscopy.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MOTS has been successfully added to your 